Voyager Therapeutics (VYGR) Capital Expenditures Growth (3y) (2017 - 2026)
Powered by 
Analysis
Voyager Therapeutics (VYGR) Capital Expenditures Growth (3y) (2017 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Krystal Biotech | 10.27 Bn | 9.43 Bn | 112.79 Mn | 82.83% |
| 2 | CRISPR Therapeutics AG | 5.17 Bn | 5.17 Bn | - | - |
| 3 | Iovance Biotherapeutics | 3.79 Bn | 3.49 Bn | 55.72 Mn | -9.77% |
| 4 | Legend Biotech | 3.68 Bn | 2.71 Bn | 251.50 Mn | -7.20% |
| 5 | uniQure | 3.05 Bn | 3.05 Bn | 5.49 Mn | - |
| 6 | Beam Therapeutics | 2.65 Bn | 2.65 Bn | - | - |
| 7 | Precigen | 2.44 Bn | 2.44 Bn | 52.17 Mn | - |
| 8 | Sarepta Therapeutics | 2.33 Bn | 1.53 Bn | 251.87 Mn | -68.59% |
| 9 | Vericel | 1.99 Bn | 1.83 Bn | 56.40 Mn | -19.62% |
| 10 | Voyager Therapeutics | 195.27 Mn | 78.93 Mn | - | -45.12% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -45.12% |
| Mar 31, 2026 | -69.81% |
| Dec 31, 2025 | -12.46% |
| Sep 30, 2025 | -9.36% |
| Jun 30, 2025 | 1.65% |
| Mar 31, 2025 | 42.37% |
| Dec 31, 2024 | -23.56% |
| Sep 30, 2024 | -26.88% |
| Jun 30, 2024 | 62.11% |
| Mar 31, 2024 | 78.73% |
| Dec 31, 2023 | -40.34% |
| Sep 30, 2023 | -46.66% |
| Jun 30, 2023 | -13.69% |
| Mar 31, 2023 | -30.36% |
| Dec 31, 2022 | -34.86% |
| Sep 30, 2022 | -38.13% |
| Jun 30, 2022 | -20.12% |
| Mar 31, 2022 | -40.89% |
| Dec 31, 2021 | -12.78% |
| Sep 30, 2021 | -8.05% |